NCT02711137 2025-10-21Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesIncyte CorporationPhase 1/2 Terminated137 enrolled 31 charts
NCT00268242 2018-02-22Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid LeukemiaThe Cleveland ClinicPhase 2 Terminated24 enrolled 10 charts